Detalhe da pesquisa
1.
Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society.
Eur Heart J
; 44(39): 4157-4173, 2023 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37611089
2.
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance.
Eur Heart J
; 44(25): 2277-2291, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37130090
3.
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.
Eur Heart J
; 43(39): 3925-3946, 2022 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36036785
4.
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society.
Eur Heart J
; 42(47): 4791-4806, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34472586
5.
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.
Cardiovasc Diabetol
; 18(1): 71, 2019 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31164165
6.
Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract.
Eur Heart J
; 39(27): 2526-2539, 2018 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29718253
7.
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.
Eur Heart J
; 38(32): 2459-2472, 2017 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28444290
8.
PCSK9 inhibitors and cardiovascular disease: heralding a new therapeutic era.
Curr Opin Lipidol
; 26(6): 511-20, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26780005
9.
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia.
Eur Heart J
; 39(14): 1131-1143, 2018 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045644
10.
New prospects for PCSK9 inhibition?
Eur Heart J
; 39(27): 2600-2601, 2018 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29579192
11.
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society.
Atherosclerosis
; 374: 107-120, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37188555
12.
Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force.
Atherosclerosis
; 325: 99-109, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33892925
13.
Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement.
Lancet Diabetes Endocrinol
; 8(1): 50-67, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582260
14.
PCSK9 inhibition, atherosclerotic cardiovascular disease, and health economics: Challenges at the crossroads.
J Clin Lipidol
; 13(5): 714-720, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31427270
15.
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.
Diab Vasc Dis Res
; 5(4): 319-35, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18958843
16.
Homozygous Familial Hypercholesterolaemia International Clinical Collaboration (HICC) registry: Levelling up access to treatment urgently needed.
Atherosclerosis
; 346: 84-85, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35246317
17.
Novel insights into lipoprotein(a): News from Atherosclerosis.
Atherosclerosis
; 345: 41-43, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35151469
18.
Joint statement from the European Atherosclerosis Society and European Society of Vascular Medicine focuses on patients with peripheral arterial disease.
Atherosclerosis
; 340: 48-50, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34863531
19.
Global Familial Hypercholesterolaemia Studies Collaboration (FHSC).
Atherosclerosis
; 337: 57-58, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34686380
20.
Should we treat high LDL cholesterol in 'healthy' elderly individuals?
Atherosclerosis
; 317: 50-51, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33334551